Profil bibliographique

Edward Bagirigomwa

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

6Publications signalées

87Citations signalées

0Affiliations récentes

Domaines associés

HIV/AIDS drug development and treatmentHIV/AIDS Research and InterventionsHIV-related health complications and treatmentsTuberculosis Research and EpidemiologyHIV Research and Treatment

Publications récentes

Accès ouvert 2025 articleOpenAlex

Population pharmacokinetics of ritonavir as a booster of lopinavir, atazanavir, or darunavir in African children with HIV

Lufina Tsirizani, Hylke Waalewijn, Alexander J. Szubert, Veronica Mulenga et autres

1 citationAntimicrobial Agents and Chemotherapy

Accès ouvert 2024 articleOpenAlex

Population Pharmacokinetics of Dolutegravir in African Children: Results From the CHAPAS-4 Trial

Hylke Waalewijn, Roeland E. Wasmann, Alasdair Bamford, Diana M. Gibb et autres

2 citationsJournal of the Pediatric Infectious Diseases Society

Accès ouvert 2023 articleOpenAlex

Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial

Anna Turkova, Ellen White, Adeodata Kekitiinwa, Vivian Mumbiro et autres

11 citationsThe Lancet Child & Adolescent Health

Accès ouvert 2023 articleOpenAlex

Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial

Alexandra Compagnucci, Man K. Chan, Yacine Saïdi, Tim R. Cressey et autres

16 citationsEClinicalMedicine

Accès ouvert 2022 articleOpenAlex

Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial

Pauline Amuge, Abbas Lugemwa, Ben Wynne, Hilda Mujuru et autres

33 citationsThe Lancet HIV

Accès ouvert 2022 articleOpenAlex

Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

Anna Turkova, Hylke Waalewijn, Man K. Chan, Pauline Bollen et autres

24 citationsThe Lancet HIV

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.